Day 1: Monday October 4, 2010

Keynote Presentation
Columbus Ballroom, Level 4
12:00-12:30
- A. Alfred Taubman, Founder and Chair, A. Alfred Taubman Medical Research Institute, USA
- Eva Feldman, University of Michigan Health System, USA

Expert Luncheons
1:00-2:30
Cabot and Cartier Ballrooms, Level 4
(Exhibit Hall Opens)

Tissue Specific Stem Cell Research and Application I
Cartier Ballroom, Level 4
2:30-3:30 - Science Session
Moderator:
Jack T. Mosher, University of Michigan, USA
Speakers:
- Yukiko Yamashita, University of Michigan, USA
- Sally Temple, Neural Stem Cell Institute, USA
- Anthony Hollander, University of Bristol, UK

Stem Cell Progress Report—Diabetes
Joliet, Level 5
2:30-3:30 - Society Session
Moderator:
- Juan Dominguez-Bendala, Diabetes Research Institute, USA
- Kevin D'Amour, ViaCyte, USA
- Robert Hindle, Genetics Policy Institute, Canada

Effective Tools for Public Education, Presented by Michigan Citizens for Stem Cell Research & Cures
Mackinac Ballroom, Level 5
2:30-3:30 - Society Session
Moderator:
- Sheri Mark, Michigan Citizens for Stem Cell Research & Cures, USA
Speakers:
- Danny Heumann, Heumannly Capable, USA
- Laura Jackson, Patient and Advocate, USA
- Marilyn Hysen, Michigan Citizens for Stem Cell Research & Cures, USA
- Ellen Cogen-Lipton, Michigan State Representative, House District 27, USA

Embryonic Stem Cell Research Oversight Committee (ESCRO) Workshop 
Duluth, Level 5
2:30-3:30 - Society Session
Moderator:
- James Shayman, University of Michigan, USA
Speakers:
- Melinda Abelman, Partners HealthCare System, USA
- Lance Gable, Wayne State University, USA
- Lois Brako, University of Michigan, USA

The Outlook for the Cord Blood, Cell Therapy and Bio Banking Industries
Nicolet, Level 5
2:30-3:30 - Industry Session
Moderator:
- Sumi Dinda, Oakland University, USA
Speakers:
- William Prather, Pluristem Therapeutics, Inc.
- Thomas Klein, Cytolon AG, USA
- George Wilson, Beaumont Hospitals, USA

Devices and Tools for Research and Industry
Cabot Ballroom, Level 4
2:30-3:30 - Industry Session
Moderator:
- Brad Calvin, Beckman Coulter, USA
Speakers:
- Keith Murphy, Organovo, USA
- Kristi A. Hohenstein Elliot, Cyntellect, USA
- Albert Donnenberg, University of Pittsburgh, USA

Regenerative Medicine Against Aging—Technological, Political and Commercial Obstacles and Opportunities
Columbus Ballroom, Level 4
2:30-3:30 - Society Session
Moderator:
- Aubrey de Grey, SENS Foundation, USA
Speakers:
- Dan Perry, Alliance for Aging Research, USA
- Michael West, BioTime, Inc., USA
- Huber Warner, University of Minnesota, USA

Financing Pathways for Cell Based Therapies
Marquette, Level 5
2:30-3:30 - Industry Session
Moderator:
- Robin Smith, NeoStem Inc., USA
Speakers:
- Denis O'Donnell, Seaside 88 Advisors, USA
- Jason Kolbert, National Securities, USA
- R. Douglas Armstrong, LifeTech Capital, USA

Cellular Reprogramming Science Presentations
Cartier Ballroom, Level 4
3:30-4:30 - Science Session
Moderator:
- Graham Parker, WSU School of Medicine, USA 
Speakers: 
- Carol Brenner, Wayne State University, USA
- M. William Lensch, Harvard Stem Cell Institute, USA
- Jason Knott, Michigan State University, USA

Michigan's Role in Stem Cell Research and as a Center for Regenerative Medicine Commercialization
Cabot Ballroom, Level 4
3:30-4:30 - Industry Session
Moderator:
- Steve Rapundalo, MichBio, USA
Speakers: 
- James Eliason, TechTown, USA
- Jeff Mason, Michigan's University Research Corridor, USA
- Timothy Mayleben, Aastrom Biosciences, USA

The NIH Guidelines and Sherley v. Sebelius - Implications for the Future of Stem Cell Research
Mackinac Ballroom, Level 5
3:30-4:30 - Society Session
Moderator:
- Alan Jakimo, Sidley Austin, USA
Speakers: 
- Rosario Isasi, McGill University, Canada
- Karen Rothenberg, University of Maryland School of Law, USA
- Geoffrey Lomax, California Institute for Regenerative Medicine, USA

A Consumer Guide—Clinical Uses of Stem Cells Derived from Cord Blood
Columbus Ballroom, Level 4
3:30-4:30 - Society Session
Moderator:
- Rasul Chaudhry, Oakland University, USA
Speakers: 
- John Wagner, University of Minnesota, USA
- Rita Perlingeiro, University of Minnesota, USA
- Wise Young, Rutgers University, USA

exhibitor Networking Reception and poster viewing
 4:30-7:00
Ambassador Ballroom, Level 3

Day 2: Tuesday October 5, 2010

Networking Breakfast
Ambassador Ballroom, Level 3

Disease Modeling Science Presentations
Cartier Ballroom, Level 4
2:30-3:30 - Science Session
Speakers:
- Gary Dunbar, Central Michigan University, USA
- Dan Kaufman, University of Minnesota, USA
- Jack Parent, University of Michigan Medical Center, USA

Stem Cell Progress Report - ALS, Parkinson’s and other Neurological Diseases
Marquette, Level 5
2:30-3:30 - Society Session
Moderator:
- Jeannie Fontana, Burnham Institute for Regenerative Medicine, USA
Speakers:
- Timothy Collier, Michigan State University, USA
- John Yu, Cedars-Sinai Medical Center, USA
- Kathleen Russell, Parkinson's Action Network, USA

Sustaining the Mandate for Cures - Critical Lessons from Battleground States
Mackinac Ballroom, Level 5
2:30-3:30 - Society Session
Moderator:
- Andy Meisner, Oakland County Treasurer, USA
Speakers:
- Donn Rubin, Missouri Coalition for Lifesaving Cures, USA
- Don Reed, Americans for Cures Foundation, USA
- John Schwarz, CureMichigan, USA

Stem Cell Standardization Issues
Cabot Ballroom, Level 4
2:30-3:30 - Industry Session
Moderator:
- Doug Doerfler, MaxCyte, USA
Speakers:
- Anne Plant, National Institutes of Standards and Technology, USA
- David Smith, Lonza Walkersville, Inc., USA
- Brenton McCright, Food and Drug Administration, USA
- Rob Herrera, Cell Line Genetics, USA

Pathways to Commercializing Stem Cell Therapies - Tech Transfer Perspectives
Duluth, Level 5
2:30-3:30 - Industry Session
Moderator:
- Robin Rasor, University of Michigan, USA
Speakers:
- Debra Grega, University of Michigan Medical School, USA
- Mark Rohrbaugh, National Institutes of Health (NIH), USA
- Andy DeTienne, Wisconsin Alumni Research Foundation (WARF), USA
- H. David Humes, University of Michigan, USA

Reimbursement and Insurance Solutions for Cell Therapies and Related Industries
Nicolet, Level 5
2:30-3:30 - Industry Session
Moderator:
- Dawn Driscoll, DCi Biotech, USA
Speakers:
- James Walters, Aon Insurance, USA
- Theresa Dixon, Advanced BioHealing Inc., USA

Economic Development—Stem Cells and Regenerative Medicine as an Engine for Economic Growth
Columbus Ballroom, Level 4
2:30-3:30 - Society Session
Moderator:
- Kurt Gunter, Hospira, Inc., USA
Speakers:
- Allen Goodman, Wayne State University, USA
- Chris Mason, University College London, United Kingdom
- Dan Gincel, Maryland Stem Cell Research Fund, USA

Regenerative Medicine Under the Microscope—VC and Investor Perspectives
Joliet, Level 5
2:30-3:30 - Industry Session
Moderator:
- Jeffrey Karan, Woodside Capital Partners, USA
Speakers:
- Matthew Plunkett, iPierian Inc., USA
- Albine Martin, Adjuvant Global Advisors, USA
- Robert Palay, Cellular Dynamics International, USA

Cancer Stem Cells Science Presentations
Cartier Ballroom, Level 4
3:30-4:30 - Science Session
Speakers:
- Pranela Rameshwar, New Jersey Medical School, USA
- Karen Aboody, City of Hope, USA
- Gary D. Hammer, University of Michigan, USA

Pharma's Growing Investment in Regenerative Medicine
Cabot Ballroom, Level 4
3:30-4:30 - Industry Session
Moderator:
- Frank Bonner, Stem Cells for Safer Medicines, United Kingdom
Speakers:
- Alain Vertes, Roche, Switzerland
- Joseph F. Amaral, Johnson & Johnson Corporation, USA
- Scott R. Burger, Advanced Cell & Gene Therapy LLC, USA

Finding Common Ground—The Emerging Alliance Between Advocates and Industry
Columbus Ballroom, Level 4
3:30-4:30 - Society Session
Moderator:
Bernard Siegel, Genetics Policy Institute, USA
Speakers:
- Mary Woolley, Research!America, USA
- Michael Werner, Holland & Knight, USA
- Andrew McKee, Juvenile Diabetes Research Foundation International, Canada

Hospital Perspectives on Stem Cells and Regenerative Medicine
Mackinac Ballroom, Level 5
3:30-4:30 - Industry Session
Moderator:
- Mark Rosenblum, Henry Ford Health System, USA
Speakers:
- Representative of Case Western Reserve/University Hospital of Cleveland
- David Felten, Beaumont Research Institute, USA
- John Yu, Cedars-Sinai Medical Center, USA

Day 3: Wednesday October 6, 2010

Networking Breakfast
Ambassador Ballroom, Level 3

Plenary Discussion
Toward Global Harmonization—Perspectives from International Network Leaders
Columbus Ballroom, Level 4
8:30-9:30
Moderator:
- Drew Lyall, Stem Cell Network, Canada
Speakers:
- Surapol Issaragrisil, Mahidol University, Thailand
- Rosario Isasi, McGill University, Canada
- Geoffrey Lomax, California Institute for Regenerative Medicine, USA

Tissue Specific Stem Cell Research and Application Science Presentations II
Cartier Ballroom, Level 4
10:00-11:00 - Science Session
Moderator:
- James Eliason, TechTown, USA
Speakers:
- Joshua Hare, University of Miami Miller School of Medicine, USA
- Tim Kamp, UW-Madison Medical School, USA
- Avi Treves, Sheba Medical Center Cancer Research Center, Israel

Stem Cell Progress Report—Blindness
Marquette, Level 5
10:00-11:00 - Society Session
Moderator:
- Jeff Stern, New York Neural Stem Cell Institute, USA
Speakers:
- Stephen Rose, Foundation Fighting Blindness, USA
- Thomas Reh, University of Washington, USA
- Lucian Del Priore, Columbia University, USA

The Shifting Landscape of Intellectual Property Law and Its Impact on the Future of Regenerative Medicine
Joliet, Level 5
10:00-11:00 - Industry Session
Moderator:
- Rebecca Eisenberg, University of Michigan Law School, USA
Speakers:
- Nicholas Zachariades, Novak Druce + Quigg LLP, USA
- Samuel S. Woodley, Fish and Richardson, USA
- Robin A. Chadwick, Schwegman Lundberg & Woessner, USA

Risks and Rip-Offs—Where to Draw the Line on Stem Cell Tourism
Columbus Ballroom, Level 4
10:00-11:00 - Society Session
Moderator:
- Megan Munsie, Australian Stem Cell Centre, Australia
Speakers:
- Heather Rooke, ISSCR, USA
- Stephen Byer, ALS Worldwide, USA
- David Gelber, 60 Minutes, USA

Forging Relationships between Industry and Regulators
Cabot Ballroom, Level 4
10:00-11:00 - Industry Session
Moderator:
- Michael Werner, Holland & Knight, USA
Speakers:
- Kimberly Benton, Food and Drug Administration, USA
- Adelheid Schneider, Roche Diagnostics, Germany
- Ed Field, Aldagen, Inc., USA

Stem Cell Progress Report—Spinal Cord Injury, Paralysis and MS
Mackinac Ballroom, Level 5
10:00-11:00 - Society Session
Speakers:
- Evan Snyder, Sanford-Burnham Medical Research Institute, USA
- Sally Temple, Neural Stem Cell Institute, USA
- Danny Heumann, Heumannly Capable, USA

Stem Cell Progress Report—Cancer
Nicolet, Level 5
10:00-11:00 - Society Session
Speakers:
- Max Wicha, University of Michigan Comprehensive Cancer Center, USA
- Ram Mandalam, Cellerant Therapeutics Inc, USA
- Jane Perlmutter, Gemini Group, USA

Stem Cell Education—Innovative Tools for Teachers and Students and Funding Opportunities
Duluth, Level 5
10:00-11:00 - Society Session
Speakers: 
- L. Tony Beck, National Institutes of Health, USA
- Rupa Shevde, WiCell Research Institute, USA
- Paul Cassar, University of Toronto, Canada

Pluripotency Science Presentations
Cartier Ballroom, Level 4
11:00-12:00 - Science Session
Moderator:
- K. Sue O’Shea, University of Michigan, USA
Speakers:
- Jose Cibelli, Michigan State University, USA
- Paul de Sousa, University of Edinburgh, Scotland
- Thomas Zwaka, Baylor College of Medicine, USA

Commercialization of Stem Cells and International Market Trends
Cabot Ballroom, Level 4
11:00-12:00 - Industry Session
Moderator:
- William B. Adams, International Stem Cell Corporation, USA
Speakers:
- Rafi Hofstein, MaRS Innovation, Canada
- Kelly Ganjei, Toucan Capital, USA
- Dean Tozer, Advanced BioHealing, Inc., USA

Countries Having the Competitive Edge I
Columbus Ballroom, Level 4
11:00-12:00 - Society Session
Moderator:
- Timo Faltus, University of Leipzig, Germany
Speakers:
- Kevin Price, Scottish Stem Cell Network, UK
- Abner M. Mhashilkar, International Venture Consultant, India
- Megan Munsie, Australian Stem Cell Centre, Australia

Healing Our Wounded Warriors—Armed Forces Investment in Regenerative Medicine
Mackinac Ballroom, level 5
11:00-12:00 - Society Session
Moderator:
- Stan Gerson, National Center for Regenerative Medicine, USA
Speakers:
- Arnold Caplan, Case Western Reserve University, USA
- LTC Brian D. Moore, Armed Forces Institute of Regenerative Medicine (AFIRM), USA
- Alan Harris, Neostem, USA

LUNCH
Ambassador Ballroom, Level 3
12:00-1:00

Tissue Engineering Science Presentations
Cartier Ballroom, Level 4
1:00-2:00 - Science Session
Moderator:
- Chris Mason, University College London, UK
Speakers:
- Raphael Gorodetsky, Hadassah-Hebrew University Medical Center, Israel
- Gary Smith, Assisted Reproductive Technologies Laboratories, USA
- Harald Ott, Massachusetts General Hospital Center for Regenerative Medicine, USA

Partnering and M&A: Inside Information from the Regen Dealmakers
Cabot Ballroom, Level 4
1:00-2:00 - Industry Session
Moderator:
- Morrie Ruffin, Adjuvant Global Advisors, USA
Speakers:
- Gil Van Bokkelen, Athersys, Inc., USA
- Jeff Till, EMD Millipore, USA
- Frank Gleeson, Fate Therapeutics, USA

Countries Having the Competitive Edge II
Columbus Ballroom, Level 4
1:00-2:00 - Society Session
Moderator:
- Ben Sykes, UK National Stem Cell Network, United Kingdom
Speakers:
- Ira Herrmann, Stem Cell Network NRW, Germany
- Natividad Cuende, Andalusian Initiative for Advanced Therapies, Spain

Global Clinical Trials Update
Mackinac Ballroom, Level 5
1:00-2:00 - Industry Session
Moderator:
- Dawn Driscoll, DCi Biotech, USA
Speakers:
- Jorge Moreno-Cuevas, ITESM Escuela de Salud y Biotechnología, Mexico
- Gordon Sherriff, Angel Biotechnology PLC, United Kingdom
- Steven Fischkoff, Celgene Cellular Therapeutics, USA
- Hector Ramon Martinez, Hospital San Jose Tec de Monterrey, Mexico